šŸ“Š This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Homology Medicines

1.1 - Company Overview

Homology Medicines Logo

Homology Medicines

Headquarter: United States
Founded: 20XXšŸ”’
Employees: 100-500šŸ”’
šŸŒ Website

Company description

  • Provider of genetic medicines for rare genetic diseases, leveraging a proprietary human hematopoietic stem cell-derived adeno-associated virus platform; developing Bempikibart (ADX-914), a fully human anti-IL-7RĪ± antibody to regulate adaptive immune function in Phase 2 for atopic dermatitis and alopecia areata, and ADX-097, a tissue-targeted complement regulator in Phase 2 for renal disorders and ANCA-Associated Vasculitis.

Products and services

  • ADX-097: A tissue-targeted complement pathway regulator that modulates local complement activity
  • In Phase 2 for renal disorders and ANCA-Associated Vasculitis
  • Bempikibart (ADX-914): A fully human anti-IL-7RĪ± antibody that targets IL-7RĪ± to regulate adaptive immune function
  • In Phase 2 for atopic dermatitis and alopecia areata
  • Human HSC-derived AAV Platform: A proprietary genetic medicines platform utilizing human hematopoietic stem cell-derived adeno-associated virus vectors to address rare genetic diseases by targeting underlying causes

Key contacts

šŸ”’
šŸ”’

Financial details

šŸ”’

1.2 - Competitors and similar companies to Homology Medicines

Automated Lab Solutions Logo

Automated Lab Solutions

HQ: Germany Website
  • Description: Provider of life science robotics and automation, including the CellCelector automated system for fluorescence imaging, selection, and image-based sorting/picking of single cells, clusters, adherent cell colonies, and clones from semi-solid media; rare single cell isolation; single cell cloning; stem cell picking; the Incubator FlowBox laminar flow cabinet; and automation components.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ā—ā—ā—ā—ā—
  • Total funding raised: $ā—ā—ā—m
  • Backers: ā—ā—ā—ā—ā—ā—ā—ā—ā—ā—
  • Acquisitions: ā—ā—
View full Automated Lab Solutions company profile ā†’
Moleculo Logo

Moleculo

HQ: United States Website
  • Description: Provider of technologies for generating long reads for genome analysis tools, offering a novel DNA sequencing method that delivers long, accurate reads and improves the efficiency and accuracy of many existing DNA sequencing applications.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ā—ā—ā—ā—ā—
  • Total funding raised: $ā—ā—ā—m
  • Backers: ā—ā—ā—ā—ā—ā—ā—ā—ā—ā—
  • Acquisitions: ā—ā—
View full Moleculo company profile ā†’
Variant Bio Logo

Variant Bio

HQ: United States Website
  • Description: Provider of genomics-driven drug discovery, using whole-genome sequencing and custom algorithms to identify novel, population-specific variants and disease-relevant targets. Offers research partnerships, benefit-sharing programs, and an Affordable Medicines Pledge, plus the Variant Bio Standley Fellowship for genomic data analysis and partnerships with populations with specific health-related traits.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ā—ā—ā—ā—ā—
  • Total funding raised: $ā—ā—ā—m
  • Backers: ā—ā—ā—ā—ā—ā—ā—ā—ā—ā—
  • Acquisitions: ā—ā—
View full Variant Bio company profile ā†’
NuGEN Logo

NuGEN

HQ: United States Website
  • Description: Provider of innovative genomics sample preparation solutions enabling scientists to access true biology in all samples, independent of type, quality and amount, for analysis on leading analytical platforms, ensuring robust and reproducible results for researchers seeking to predict disease
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ā—ā—ā—ā—ā—
  • Total funding raised: $ā—ā—ā—m
  • Backers: ā—ā—ā—ā—ā—ā—ā—ā—ā—ā—
  • Acquisitions: ā—ā—
View full NuGEN company profile ā†’
Rewrite Therapeutics Logo

Rewrite Therapeutics

HQ: United States Website
  • Description: Provider of novel DNA writing technologies from a private biotechnology company focused on advancing the field.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ā—ā—ā—ā—ā—
  • Total funding raised: $ā—ā—ā—m
  • Backers: ā—ā—ā—ā—ā—ā—ā—ā—ā—ā—
  • Acquisitions: ā—ā—
View full Rewrite Therapeutics company profile ā†’
šŸ”’

2.M&A buyers

2.1 Potential strategic acquirers in the sector

šŸ”’
šŸ”’
šŸ”’
šŸ”’ View all strategic buyers with complete profiles
Start Free Trial ā†’

2.2 - Strategic buyer groups for Homology Medicines

šŸ”’

Buyer group 1: ā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆ ā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆ

ā—ā— companies
Description: ā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆ ā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆ ā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆ ā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆ ā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆ ā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆ ā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆ ā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆ ā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆ ā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆ
Key Products: ā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆ, ā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆ, ā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆ, ā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆ
šŸ”’ View all companies in this group
Request Free Trial Now ā†’
šŸ”’

Buyer group 2: ā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆ ā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆ

ā—ā— companies
Description: ā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆ ā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆ ā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆ ā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆ ā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆ ā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆ ā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆ ā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆ ā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆ ā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆ
Key Products: ā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆ, ā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆ, ā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆ, ā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆ
šŸ”’ View all companies in this group
Request Free Trial Now ā†’
šŸ”’

Buyer group 3: ā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆ ā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆ

ā—ā— companies
Description: ā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆ ā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆ ā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆ ā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆ ā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆ ā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆ ā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆ ā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆ ā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆ ā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆ
Key Products: ā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆ, ā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆ, ā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆ, ā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆ
šŸ”’ View all companies in this group
Request Free Trial Now ā†’
šŸ”“ Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial ā†’

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Homology Medicines

2.2 - Growth funds investing in similar companies to Homology Medicines

šŸ”’ View all growth equity funds with complete profiles
Start Free Trial ā†’

4 - Top valuation comps for Homology Medicines

4.2 - Public trading comparable groups for Homology Medicines

šŸ”“ Unlock all public trading comparable groups with complete valuation data
Start Free Trial ā†’

4.3 - M&A Transactions similar to Homology Medicines

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
šŸ”’ View all M&A transactions with complete deal terms
Request Free Trial Now ā†’

Frequently Asked Questions

About Homology Medicines

What does Homology Medicines do?

Homology Medicines is a provider of genetic medicines for rare genetic diseases, leveraging a proprietary human hematopoietic stem cell-derived adeno-associated virus platform; developing Bempikibart (ADX-914), a fully human anti-IL-7RĪ± antibody to regulate adaptive immune function in Phase 2 for atopic dermatitis and alopecia areata, and ADX-097, a tissue-targeted complement regulator in Phase 2 for renal disorders and ANCA-Associated Vasculitis.

Who are Homology Medicines's competitors?

Homology Medicines's competitors and similar companies include Automated Lab Solutions, Moleculo, Variant Bio, NuGEN, and Rewrite Therapeutics.

Where is Homology Medicines headquartered?

Homology Medicines is headquartered in United States.

How many employees does Homology Medicines have?

Homology Medicines has 1,000 employees šŸ”’.

When was Homology Medicines founded?

Homology Medicines was founded in 2010 šŸ”’.

What sector and industry vertical is Homology Medicines in?

Homology Medicines is in the Enterprise Software šŸ”’ sector and industry

M&A Buyers & Acquirers for Homology Medicines

Who are the top strategic acquirers in Homology Medicines's sector and industry

Top strategic M&A buyers and acquirers in Homology Medicines's sector include ā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆ, ā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆ, ā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆ, ā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆ, and ā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆ šŸ”’.

Which M&A buyer groups are most relevant for Homology Medicines?

Top strategic M&A buyers groups and sectors for Homology Medicines include ā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆ , ā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆ, ā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆ, ā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆ, and ā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆ šŸ”’.

Financial Investors investing in Homology Medicines's sector and industry vertical

Which are the top PE firms investing in Homology Medicines's sector and industry vertical?

Top PE firms investing in Homology Medicines's sector and industry vertical include ā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆ, ā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆ, ā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆ, and ā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆ šŸ”’.

Who are the top buyout funds acquiring in Homology Medicines's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Homology Medicines's sector and industry vertical include ā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆ, ā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆ, ā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆ, and ā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆ šŸ”’.

Who are the top growth equity funds investing in companies in Homology Medicines's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Homology Medicines include ā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆ, ā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆ, ā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆ, and ā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆ šŸ”’.

Valuation benchmarks of companies in Homology Medicines's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Homology Medicines?

The key public trading comparables and valuation benchmarks for Homology Medicines include ā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆ, ā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆ, ā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆ, and ā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆā–ˆ šŸ”’.

Which are the key trading comparable groups for Homology Medicines for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Homology Medicines with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Homology Medicines's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Homology Medicines with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Homology Medicines's' sector and industry vertical?

Access recent funding rounds and capital raises in Homology Medicines's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Homology Medicines